Insulin aspart, recombinant Subcutaneous and Tri Biozene
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tri Biozene and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: bacitracin / neomycin / polymyxin b / pramoxine topical
Brand name: Neosporin + Pain Relief Ointment, Tri Biozene
Synonyms: Bacitracin, Neomycin, Polymyxin B, and Pramoxine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tri Femynor
- Insulin aspart, recombinant Subcutaneous-Tri Vites with Fluoride and Iron
- Insulin aspart, recombinant Subcutaneous-Tri-Estarylla
- Insulin aspart, recombinant Subcutaneous-Tri-Legest
- Insulin aspart, recombinant Subcutaneous-Tri-Legest Fe
- Insulin aspart, recombinant Subcutaneous-Tri-Linyah
- Tri Biozene-Insulin degludec
- Tri Biozene-Insulin Degludec (U-100) Prefilled Pens
- Tri Biozene-Insulin Degludec (U-100) Vials
- Tri Biozene-Insulin Degludec (U-200) Prefilled Pens
- Tri Biozene-Insulin degludec and liraglutide
- Tri Biozene-Insulin degludec and liraglutide Subcutaneous